This project has been flagged by a community member as inappropriate due to reason below.*
Expert Interview
Slingshot members are talking to an expert! The topic is:
Discussing targets in TED (IGF-1R, IL-6 & FcRn class), including their available clinical data.
Ticker(s): HZNP, VRDN, IMVT, ARGXWho's the expert?
Institution: Cedars Sinai
- Professor and Head of Orbital and Thyroid Eye Disease Programs at Cedars Sinai Hospital.
- Pioneered the Aesthetic Orbital Decompression technique, which addresses both eye aesthetic and function.
- Internationally recognized as a key player in the development and use of TEPEZZA (Teprotumumab).
- Research focuses on aesthetic and reconstructive oculoplastic surgery as well as thyroid eye disease treatment and transformations.
Are You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
